VNRX
VolitionRx Limited
NYSE · Healthcare
VolitionRx Limited annual/quarterly operating income history and growth rate from 2011 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- VolitionRx Limited operating income for the quarter ending March 31, 2026 was -5.3 M, a 3.13% decrease year-over-year.
- VolitionRx Limited operating income for the twelve months ending March 31, 2026 was -22.3 M, a 25.51% decrease year-over-year.
- VolitionRx Limited annual operating income for 2025 was -21.7 M, a 19.56% decrease from 2024.
- VolitionRx Limited annual operating income for 2024 was -27.0 M, a 24.90% decrease from 2023.
- VolitionRx Limited annual operating income for 2023 was -36.0 M, a 13.24% increase from 2022.
- VolitionRx Limited annual operating income for 2022 was -31.8 M.
Operating Income
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %